BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17081643)

  • 1. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules.
    Ponce S; Orive G; Hernández RM; Gascón AR; Canals JM; Muñoz MT; Pedraz JL
    J Control Release; 2006 Nov; 116(1):28-34. PubMed ID: 17081643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules.
    Murua A; de Castro M; Orive G; Hernandez RM; Pedraz JL
    Biomacromolecules; 2007 Nov; 8(11):3302-7. PubMed ID: 17941669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules.
    De Castro M; Orive G; Hernández RM; Bartkowiak A; Brylak W; Pedraz JL
    J Biomed Mater Res A; 2009 Dec; 91(4):1119-30. PubMed ID: 19145624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts.
    Murua A; Orive G; Hernández RM; Pedraz JL
    Biomaterials; 2009 Jul; 30(20):3495-501. PubMed ID: 19327822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics.
    Koch S; Schwinger C; Kressler J; Heinzen Ch; Rainov NG
    J Microencapsul; 2003; 20(3):303-16. PubMed ID: 12881112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating.
    King A; Strand B; Rokstad AM; Kulseng B; Andersson A; Skjåk-Braek G; Sandler S
    J Biomed Mater Res A; 2003 Mar; 64(3):533-9. PubMed ID: 12579568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules.
    Orive G; De Castro M; Ponce S; Hernández RM; Gascón AR; Bosch M; Alberch J; Pedraz JL
    Mol Ther; 2005 Aug; 12(2):283-9. PubMed ID: 15935736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility evaluation of different alginates and alginate-based microcapsules.
    Orive G; Carcaboso AM; Hernández RM; Gascón AR; Pedraz JL
    Biomacromolecules; 2005; 6(2):927-31. PubMed ID: 15762661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression.
    Murua A; Orive G; Hernández RM; Pedraz JL
    J Control Release; 2009 Aug; 137(3):174-8. PubMed ID: 19376171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.
    Li HB; Jiang H; Wang CY; Duan CM; Ye Y; Su XP; Kong QX; Wu JF; Guo XM
    Biomed Mater; 2006 Mar; 1(1):42-7. PubMed ID: 18458385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged gelling time on the intrinsic properties of barium alginate microcapsules and its biocompatibility.
    Vaithilingam V; Kollarikova G; Qi M; Lacik I; Oberholzer J; Guillemin GJ; Tuch BE
    J Microencapsul; 2011; 28(6):499-507. PubMed ID: 21827357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy.
    Orive G; Tam SK; Pedraz JL; Hallé JP
    Biomaterials; 2006 Jul; 27(20):3691-700. PubMed ID: 16574222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination.
    Dusseault J; Tam SK; Ménard M; Polizu S; Jourdan G; Yahia L; Hallé JP
    J Biomed Mater Res A; 2006 Feb; 76(2):243-51. PubMed ID: 16265647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of residual contamination on the biofunctional properties of purified alginates used for cell encapsulation.
    Tam SK; Dusseault J; Polizu S; Ménard M; Hallé JP; Yahia L
    Biomaterials; 2006 Mar; 27(8):1296-305. PubMed ID: 16154192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition.
    Ponce S; Orive G; Hernández R; Gascón AR; Pedraz JL; de Haan BJ; Faas MM; Mathieu HJ; de Vos P
    Biomaterials; 2006 Oct; 27(28):4831-9. PubMed ID: 16766026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a composite drug delivery system to prolong functionality of cell-based scaffolds.
    Murua A; Herran E; Orive G; Igartua M; Blanco FJ; Pedraz JL; Hernández RM
    Int J Pharm; 2011 Apr; 407(1-2):142-50. PubMed ID: 21094235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules.
    Haque T; Chen H; Ouyang W; Martoni C; Lawuyi B; Urbanska AM; Prakash S
    Mol Pharm; 2005; 2(1):29-36. PubMed ID: 15804175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates.
    Orive G; Ponce S; Hernández RM; Gascón AR; Igartua M; Pedraz JL
    Biomaterials; 2002 Sep; 23(18):3825-31. PubMed ID: 12164186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of alginate-poly-L-lysine-alginate microcapsules by confocal laser scanning microscopy.
    Strand BL; Mørch YA; Espevik T; Skjåk-Braek G
    Biotechnol Bioeng; 2003 May; 82(4):386-94. PubMed ID: 12632394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells.
    Acarregui A; Pedraz JL; Blanco FJ; Hernández RM; Orive G
    Biomacromolecules; 2013 Feb; 14(2):322-30. PubMed ID: 23231457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.